France Cardiovascular Devices Market Analysis, Data & Statistics: Diagnostic and Monitoring Devices (ECG, Holter monitors, Event monitors, Echocardiogram, Implantable loop recorders, PET, MRI, CT, Doppler fetal monitor); Surgical Devices (Coronary Stents, Pacemakers, Defibrillators, Interventional Cardiac Devices, Heart Valves, Cardiac Ablation Catheters, Ventricular Assist Devices), Region: as Île-de-France, Auvergne-Rhône-Alpes, Nouvelle-Aquitaine, Occitanie, Hauts-de-France, Provence-Alpes-Côte d’Azur, Grand Est and others

France Cardiovascular Devices market size is estimates to be $XX million in 2022. Heart failure prevalence in European nations ranges from 0.4 percent to 2 percent. With age, it increases drastically. In France, there are about 500,000 heart failure patients and 120,000 new cases are diagnosed each year. Over 74 years old make up two-thirds. Heart failure causes 3.5 million visits to outpatient clinics annually and 150,000 hospitalizations in hospitals. An average hospital stay lasts 11 days. Cardiac failure is responsible for more than 32,000 fatalities. More than 1% of the total medical budget is spent on heart failure.

According to the most recent WHO data, In 2020 France has a record of 63,181or 13.22 percent death from coronary disease. France is ranked #182 in the world by age-adjusted Death Rate, which is 30.17 per 100,000 of the population.

in France cardiovascular diseases (CVDs) are the second biggest cause of death, accounting for 27% of the 535,000 fatalities in 2011. More specifically, cerebrovascular disease and ischaemic heart disease (standardized death rate of 7 percent and 6 percent, respectively). The female and male ratios for these last two causes of death were 1.3 and 2.4, respectively. However, between 2009 and 1990, the age-standard death rates for cerebrovascular disease and ischemic heart disease dropped by 48 and 55% respectively. Crude hospitalization rates for ischemic heart disease were 339/100,000 in 2012, acute coronary syndromes were 188/100,000, myocardial infarction was 94/100,000, the cerebrovascular disease was 224/100,000, and heart failure was 239/100,000. Between 2002 and 2012, both gender standardized hospitalization rates for each of these illnesses declined, though with varying amplitudes. However, throughout the same period, the usual hospitalization rates for stroke among patients under 65 years of age increased (+13.3 percent for males and +16.3 percent for women).

One-fourth of the total disease burden is attributable to unhealthy lifestyles. In 2015 IHME estimates that approximately 25% of the total burden of diseases could be attributed to behavioral risk factors. tobacco use (9.7%), dietary hazards (8.2 percent), drinking alcohol (5.3 percent), and not exercising (2.0 percent ) contributed the most to DALYs in 2015 (IHME, 2016)Adults in France smoked daily at a rate of 22%, down from 27% in 2000, but still higher than the average rate in the EU. Smoking is particularly concerning.

France Cardiovascular Devices Market by States

• Île-de-France
• Auvergne-Rhône-Alpes
• Nouvelle-Aquitaine
• Occitanie
• Hauts-de-France
• Provence-Alpes-Côte d’Azur
• Grand Est
• Rest of France

France Cardiovascular Devices market has been spilt into regions namely Île-de-France, Auvergne-Rhône-Alpes, Nouvelle-Aquitaine, Occitanie, Hauts-de-France, Provence-Alpes-Côte d’Azur, Grand Est & others.

France Cardiovascular Devices Market Segments

Datavagyanik has covered each Cardiovascular Devices in detail in terms of market size, sales volume, growth forecast. The segment and sub segment level categorization covered in the report are:

• Diagnostic and Monitoring Devices
  • ECG
  • Holter monitors
  • Event monitors
  • Echocardiogram
  • Implantable loop recorders
  • PET
  • MRI
  • CT
  • Doppler fetal monitor
• Surgical Devices
  • Coronary Stents
  • Pacemakers
  • Defibrillators
  • Interventional Cardiac Devices
  • Heart Valves
  • Cardiac Ablation Catheters
  • Ventricular Assist Devices

Key questions answered in the France Cardiovascular Devices Market Analysis Report:

• What is the market size for cardiovascular disease treatment in France?
• What is the overall cardiovascular devices market size in France, how is the demand rising and what is market for devices (diagnostics & monitoring devices, surgical devices)?
• What is the market size for cardiovascular diagnostics (ECG, Holter monitors, Event monitors, Echocardiogram, Implantable loop recorders, PET, MRI, CT, Doppler fetal monitor) in France?
• What is the market size for cardiovascular surgical devices (Coronary Stents, Pacemakers, Defibrillators, Interventional Cardiac Devices, Heart Valves, Cardiac Ablation Catheters, Ventricular Assist Devices) in France?
• Who are the top market players by market share, in each product segment?
• Which is the fastest growing business/ product segment?
• What should be the business strategies and Go to Market strategies?

Cardiovascular Devices in France: Report Deliverables

1. Summary Statistics
   • Cardiovascular Devices in France Market Attractiveness Analysis

• Cardiovascular Diagnostics & Monitoring Devices Market in France
• Cardiovascular Surgical Devices Market in France

1. Cardiovascular Devices in France Market Analysis, by Segment (state level analysis)
   • Overview
   • Historical Market size ($Million), (2017 – 2021)
   • Market size ($Million), and Forecasts (2022 – 2027)
2. Market Analysis by Segment (state level analysis)
   • End Users (Hospitals, Ambulatory Surgery Centers, Diagnostics Centers, others)
   • Application (Coronary Heart Disease, Sudden Cardiac Arrest, Stroke, Rheumatic Heart Disease, Cerebrovascular Heart Disease, Others)
3. Region wise analysis

• as Île-de-France revenue & volume (Cardiovascular Diagnostics, Monitoring and Surgical Devices)
• Auvergne-Rhône-Alpes revenue & volume (Cardiovascular Diagnostics, Monitoring and Surgical Devices)
• Nouvelle-Aquitaine revenue & volume (Cardiovascular Diagnostics, Monitoring and Surgical Devices)
• Occitanie revenue & volume (Cardiovascular Diagnostics, Monitoring and Surgical Devices)
• Hauts-de-France, Provence-Alpes-Côte d’Azur, Grand Est, Rest of France revenue & volume (Cardiovascular Diagnostics, Monitoring and Surgical Devices)

5. Pricing analysis
   • Cardiovascular disease diagnostics and treatment cost in France
   • Price trend and factors that impact product prices in France
6. Market forecast for 10 years
7. Investment strategies